Krystle J. Nomie, Ph.D.
Affiliations: | 2009 | Cell Biology | Duke University, Durham, NC |
Google:
"Krystle Nomie"Parents
Sign in to add mentor| Robin P. Wharton | grad student | 2009 | Duke | |
| (Pumilio-mediated repression of mRNAs in the early Drosophila melanogaster embryo.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Radtke AJ, Postovalova E, Varlamova A, et al. (2024) Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients. Cancer Cell |
| Jain P, Nomie K, Kotlov N, et al. (2023) Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma. Blood Cancer Journal. 13: 156 |
| Han G, Deng Q, Marques-Piubelli ML, et al. (2022) Follicular lymphoma microenvironment characteristics associated with tumor cell mutations and MHC class II expression. Blood Cancer Discovery |
| Zhang S, Jiang VC, Han G, et al. (2021) Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma. Nature Communications. 12: 2877 |
| Razzaghi R, Agarwal S, Kotlov N, et al. (2021) Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphoma. The Journal of Experimental Medicine. 218 |
| Guo WH, Qi X, Yu X, et al. (2020) Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry. Nature Communications. 11: 4268 |
| Hill HA, Qi X, Jain P, et al. (2020) Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis. Blood Advances. 4: 2927-2938 |
| Zhao S, Kanagal-Shamanna R, Navsaria L, et al. (2020) Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients. American Journal of Hematology |
| Jain P, Zhang S, Kanagal-Shamanna R, et al. (2020) Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL. Blood Advances. 4: 1038-1050 |
| Nomie K, Jain P, Kotlov N, et al. (2020) Correlation of PI3K upregulation with NOTCH2 mutations in ibrutinib-resistant mantle cell lymphoma. Journal of Clinical Oncology. 38: e20065-e20065 |